Announcement on Voluntary Disclosure of Subsidiary Passing ANVISA GMP Certification
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Announcement on Voluntary Disclosure of Subsidiary Passing ANVISA GMP Certification
Filed with SSE · · 2 pages · Chinese
On 6ix: 6ix.com/news/announcement-on-voluntary-disclosure-of-subsidiary-passing-anvisa-gmp-certification
Release
Hunan Warrant Pharmaceutical Co., Ltd. on 6ix
Earlier from Hunan Warrant Pharmaceutical
- Announcement on Preliminary Earnings Estimate for 2025
- Announcement on Voluntary Disclosure of Selection of Products for Continuation Procurement Under National Procurement Scheme After Agreement Expiry
- Announcement on Voluntary Disclosure of Receipt by the Joint-stock Company of the Phase I Clinical Study Report for ZG-002 Tablets
- Announcement on Completing Industrial and Commercial Change Registration and Obtaining Renewed Business License
- Announcement on Voluntary Disclosure of Withdrawal of Drug Registration Application
Later from Hunan Warrant Pharmaceutical
- Announcement on Voluntary Disclosure of Subsidiary Passing On-site Inspection by FDA
- Indicative Announcement on a Controlling Shareholder Adding a Person Acting in Concert and the Internal Transfer of Shares by Agreement Among Persons Acting in Concert, Resulting in Change of Equity
- Announcement on a Controlling Shareholder Adding a Person Acting in Concert and the Completion of Internal Transfer of Shares by Agreement Among Persons Acting in Concert
- Announcement on Adjusting Grant Price and Amount in 2024 Restricted Stock Incentive Plan
- Science and Technology for People's Well-being - Achievement of Enterprises on SSE STAR Market and Its Empowerment of People's Livelihood Conference
Follow Hunan Warrant Pharmaceutical into a list and get an email when it puts out news.
Follow Hunan Warrant Pharmaceutical